Analyst says GN Hearing's acquisition will build bridges and bring in customers

Acquiring US-based Lively should be seen a step in GN Hearing's preparations for the upcoming over-the-counter sales channel in the US, says Senior Equity Analyst at Sydbank Søren Løntoft Hansen.

Photo: GN Hearing / PR

It makes sense for GN Hearing to take over US-based hearing healthcare firm Lively, opines Senior Equity Analyst at Sydbank Søren Løntoft Hansen following the announced acquisition by GN Hearing on Tuesday.

"It's a smaller acquisition but it makes sense," Løntoft Hansen tells MarketWire.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs